KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Receivables (2016 - 2025)

Johnson & Johnson's Receivables history spans 17 years, with the latest figure at $17.2 billion for Q4 2025.

  • For Q4 2025, Receivables rose 15.74% year-over-year to $17.2 billion; the TTM value through Dec 2025 reached $17.2 billion, up 15.74%, while the annual FY2025 figure was $17.2 billion, 15.74% up from the prior year.
  • Receivables for Q4 2025 was $17.2 billion at Johnson & Johnson, down from $17.6 billion in the prior quarter.
  • Across five years, Receivables topped out at $17.8 billion in Q2 2025 and bottomed at $13.6 billion in Q1 2021.
  • The 5-year median for Receivables is $15.6 billion (2022), against an average of $15.6 billion.
  • The largest annual shift saw Receivables decreased 8.59% in 2024 before it rose 15.74% in 2025.
  • A 5-year view of Receivables shows it stood at $14.9 billion in 2021, then increased by 6.57% to $15.9 billion in 2022, then fell by 6.4% to $14.9 billion in 2023, then dropped by 0.21% to $14.8 billion in 2024, then increased by 15.74% to $17.2 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Receivables are $17.2 billion (Q4 2025), $17.6 billion (Q3 2025), and $17.8 billion (Q2 2025).